Arterial Revascularisation Trial - a randomised trial to compare survival following bilateral versus single internal mammary artery (IMA) grafting in coronary revascularisatio
- Conditions
- CardiovascularCirculatory SystemArterial revascularisation
- Registration Number
- ISRCTN46552265
- Lead Sponsor
- niversity of Oxford (UK)
- Brief Summary
2006 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/16573820 protocol 2010 Results article in http://www.ncbi.nlm.nih.gov/pubmed/20805116 results 2011 Other publications in http://www.ncbi.nlm.nih.gov/pubmed/21943128 assessment of data quality 2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/25217501 results 2016 Results article in http://www.ncbi.nlm.nih.gov/pubmed/27112712 results 2016 Results article in https://www.ncbi.nlm.nih.gov/pubmed/27959712 results 2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/28566338 results 2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/28450552 results 2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29502105 results 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30699314 results 2019 Results article in https://pubmed.ncbi.nlm.nih.gov/30948516/ results (added 11/06/2020)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 3102
Coronary artery bypass graft (CABG) patients with multi-vessel coronary artery disease (including urgent and off pump CABG patients)
1. Single graft
2. Redo CABG
3. Evolving myocardial infarction
4. Concomitant valve surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Current primary outcome measure as of 26/10/2021:<br>Survival will be measured using patient telephone follow-up or by national databases where applicable at 10 and 15 years. <br> <br><br>Previous primary outcome measure:<br>Survival
- Secondary Outcome Measures
Name Time Method